Asthma & ABPA Pre-Screening Study

  • Research type

    Research Study

  • Full title

    A Prescreening Study to Diagnose Allergic Bronchopulmonary Aspergillosis in Selected Patients with Asthma



  • Contact name

    Rory Taylor

  • Contact email

  • Sponsor organisation

    Pulmatrix Inc

  • Identifier


  • Duration of Study in the UK

    0 years, 7 months, 5 days

  • Research summary

    This prescreening study is to diagnose Allergic Bronchpulmonary Aspergillosis (ABPA)in selected patients with asthma. In turn, this will increase the potential number of eligible participants for an ongoing study (IRAS 1006803) investigating an inhaler for ABPA sufferers.

    Participants involvement in the study will only last for between 2-4 weeks.

    The study's aiming to recruit patients over the age of 18 who have a diagnosis of asthma and have had at least one exacerbation that required treatment in the last 10 months.

  • REC name

    Wales REC 7

  • REC reference


  • Date of REC Opinion

    21 Dec 2023

  • REC opinion

    Further Information Favourable Opinion